(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-((1-(4-sulfamoylphenyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3-yl acetate

InChIKey	`GPDJEOLNUXCUQS-WRQOLXDDSA-N`
Compound Name	(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-((1-(4-sulfamoylphenyl)-1H-1,2,3-triazol-4-yl)methoxy)tetrahydro-2H-pyran-3-yl acetate
Canonical SMILES	`CC(=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](OCc2cn(-c3ccc(S(N)(=O)=O)cc3)nn2)O[C@@H]1CO`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.82
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00915	CA1	Homo sapiens	Human	PF00194	8.2	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	8.1	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	8.1	pIC50	TTD_MultiTarget
Q16790	CA9	Homo sapiens	Human	PF00194	7.0	Ki	ChEMBL;BindingDB